We serve Chemical Name:4,6-Difluorooxindole CAS:247564-57-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4,6-Difluorooxindole
CAS.NO:247564-57-4
Synonyms:4,6-difluoro-2H-indol-2-one;2H-Indol-2-one, 4,6-difluoro-1,3-dihydro-;4,6-DIFLUORO-2-OXOINDOLE;4,6-difluoroindolin-2-one;4,6-Difluoro-1,3-dihydro-2H-indol-2-one;MFCD01075217;T56 BMV DHJ FF HF;4,6-Difluorooxindole;4,6-Difluoro-2-oxyindole
Molecular Formula:C8H5F2NO
Molecular Weight:169.128
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:264.9±40.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.536
PSA:29.10000
Exact Mass:169.033920
LogP:2.25
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4,6-difluoro-2H-indol-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,6-Difluoro-2-oxyindole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD01075217 Use and application,T56 BMV DHJ FF HF technical grade,usp/ep/jp grade.
Related News: Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process. 4,6-Difluorooxindole manufacturer As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. 4,6-Difluorooxindole supplier As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. 4,6-Difluorooxindole vendor Though Innova previously applied for a regulatory green light, the test has not been authorized or approved by the FDA for use in the U.S.—however, during inspections of the company’s California facilities in March and April, FDA investigators said they found the test was already being sold and distributed. 4,6-Difluorooxindole factory For example, there are concerns that PFAS’ effect on the thyroid could lead to thyroid cancer, van Gerwen said.
